Cancer chemoprevention and cancer preventive vaccines - A call to action: Leaders of diverse stakeholder groups present strategies for overcoming multiple barriers to meet an urgent need

Cancer Research

Volumn 66, Issue 24, 2006, Pages 11540-11549

  Herberman, Ronald B ^a   Pearce, Homer L ^b   Lippman, Scott M ^c   Pyenson, Bruce S ^d   Alberts, David S ^e  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b ELI LILLY AND COMPANY   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d MILLIMAN INC   (United States)

^e UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE;

CANCER IMMUNIZATION; CANCER PREVENTION; CANCER RESEARCH; CHEMOPROPHYLAXIS; CLINICAL RESEARCH; CONFERENCE PAPER; DRUG RESEARCH; FINANCIAL MANAGEMENT; FOOD AND DRUG ADMINISTRATION; FUNDING; HEALTH INSURANCE; PATENT; PATIENT EDUCATION; PATIENT PARTICIPATION; PRIORITY JOURNAL; PUBLIC OPINION; REIMBURSEMENT; RESEARCH SUBJECT;

ANTICARCINOGENIC AGENTS; CANCER VACCINES; CHEMOPREVENTION; CLINICAL TRIALS; HUMANS; NEOPLASMS; RESEARCH DESIGN;

EID: 33846229131     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-06-4122     Document Type: Conference Paper

References (17)

1. Cancer facts and figures 2006. American Cancer Society.
2. Tsao AS, Kim ES, Ki Hong W. Chemoprevention of cancer. CA Cancer J Clin 2004;54:150-80.
3. Ashford L, Collymore Y. Preventing cervical cancer worldwide, Population Reference Bureau, Policy Brief, 2005.
4. O'Shaughnessy JA, Kelloff GJ, Gordon GB, et al. Treatment and prevention of intraepithelial neoplasia, an important target for accelerated new agent development. Clin Cancer Res 2002;8:314-46.
5. Kelloff G, Lippman SM, Dannenberg AJ, et al. Progress in chemoprevention drug development: the promise of molecular biomarkers for prevention of intraepithelial neoplasia and cancer-a plan to move forward. Clin Cancer Res 2006;12:3661-97.
6. American Cancer Society, http://www.cancer.org/ docrott/NWS/content? NWS_1_1x_Encouraging_ Participation_in_Clinical_Trials. Encouraging Participation in Clinical Trials, September 7, 1999.
7. National Cancer Institute Cancer Clinical Trials: The Basic Workbook, http://www.cancer.gov/clinicaltrials/resources/basicworkbook/.
8. Intercultural Cancer Council, Cancer Clinical Trials. http://iccnetwork.org/cancerfacts/cfs11.htm.
9. SELECT Selenium and Vitamin E Cancer Prevention Trial. http://www.crab.org/select/.
10. Smith C, Cowan C, Sensenig A, Catlin A. Health spending growth slows in 2004. Health Affairs 2004;25:1,186-96, 2004.
11. Borger C, et al. Health spending projections through 2015: changes on thé horizon, Health Affairs Web Exclusive W61: 22 February 2006.
12. Medicare, Preventive Services, http://www.medicare. gov/Health/ otherhealth.asp.
13. Centers for Medicare & Medicaid Services, http:// www.cms.hhs.gov/home/medicaid.asp.
14. Agency for Healthcare Research and Quality. http:// www.ahcpr.gov.
15. U.S. Patent Statistics Summary Table Years 1963 to 2004, U.S. Patent and Trade Office.
16. Gerald J. Mossinghoff. Overview of the HatchWaxman Act and its impact on the drug development process. Food Drug Law J 1999;54:187-94.
17. Pugatch MP. Intellectual property and pharmaceutical data exclusivity in the context of innovation and market access. Dialogue on Ensuring Policy Options for Affordable Access to Essential Medicines, Oct. 12-16, 2004.